Tumor Necrosis Factor Inhibitors Are Associated With Reduced Complement Activation in Spondylarthropathies: An Observational Study

PLoS ONE - United States
doi 10.1371/journal.pone.0220079
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Appearance of ANCA – Associated Vasculitis Under Tumor Necrosis Factor-Alpha Inhibitors Treatment

American Journal of Case Reports
Medicine
2013English

Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

Archives of Dermatology
2010English

Epidemiology in Paediatric Non‐infectious Uveitis Treated With Tumor Necrosis Factor‐alpha Inhibitors: A Retrospective Study

Acta Ophthalmologica
MedicineOphthalmology
2018English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

RXFP1 Is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2015English

Higher Levels of Tumor Necrosis Factor Β Are Associated With Frailty in Socially Vulnerable Community-Dwelling Older Adults

BMC Geriatrics
GerontologyGeriatrics
2018English

Tumor Necrosis Factor Receptor 1 Associated Periodic Syndrome

2020English

Tumor Necrosis Factor-Α-Induced Cell Killing and Activation of Transcription Factor NF-κB Are Uncoupled in L929 Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Tumor Necrosis Factor

2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy